Highlights d Activation of PLTS interneurons produces NO-LTD at SPN glutamatergic synapses d NO-LTD is dependent upon cGMP signaling and expressed postsynaptically d NO-LTD is independent of activity and the origin of presynaptic terminal d NO blunts presynaptic eCb-LTD by suppressing dendritic Ltype Ca 2+ channels SUMMARY Experience-driven plasticity of glutamatergic synapses on striatal spiny projection neurons (SPNs) is thought to be essential to goal-directed behavior and habit formation. One major form of striatal plasticity, long-term depression (LTD), has long appeared to be expressed only pre-synaptically. Contrary to this view, nitric oxide (NO) generated by striatal interneurons was found to induce a post-synaptically expressed form of LTD at SPN glutamatergic synapses. This form of LTD was dependent on signaling through guanylyl cyclase and protein kinase G, both of which are abundantly expressed by SPNs. NO-LTD was unaffected by local synaptic activity or antagonism of endocannabinoid (eCb) and dopamine receptors, all of which modulate canonical, pre-synaptic LTD. Moreover, NO signaling disrupted induction of this canonical LTD by inhibiting dendritic Ca 2+ channels regulating eCb synthesis. These results establish an interneuron-dependent, heterosynaptic form of post-synaptic LTD that could act to promote stability of the striatal network during learning.
In Brief
Nitric oxide (NO) is a gaseous neurotransmitter whose intracellular machinery is expressed at abundant levels within the striatum. Historically, NO's role in striatal plasticity has been controversial. Rafalovich et al. have conducted a series of pharmacological and optogenetic studies that reveal that NO is unequivocally a mediator of striatal depression.
INTRODUCTION
The striatum has long been implicated in learning goal-directed behavior and habits (Balleine et al., 2007) . This learning is thought to reflect changes in the strength of glutamatergic synapses that dictate the timing and pattern of activity of principal spiny projection neurons (SPNs) (Gerfen and Surmeier, 2011) . In the dorsal striatum, axospinous glutamatergic synapses on SPNs are formed primarily by cortical pyramidal neurons. Long-term depression (LTD) of these synapses was initially described over 20 years ago and has been extensively studied (Calabresi et al., 1992; Centonze et al., 2001; Gerfen and Surmeier, 2011; Kreitzer and Malenka, 2008; Mathur and Lovinger, 2012) . The best-characterized form of LTD is induced by postsynaptic depolarization and activation of metabotropic glutamate receptors and L-type Ca 2+ channels, which trigger the generation of endocannabinoids (eCbs) by SPNs; expression of LTD is mediated by eCb activation of pre-synaptic CB1 receptors, which results in sustained depression of glutamate release (Kreitzer and Malenka, 2005; Lovinger et al., 1993) . Although other neuromodulators can mimic the actions of eCbs at these synapses (Mathur et al., 2011) , no post-synaptically expressed form of LTD has been described in SPNs.
One of the signaling molecules implicated in post-synaptically expressed LTD elsewhere in the brain is NO (Garthwaite, 2008) . Striatal expression of NO signaling proteins soluble guanylyl cyclase (sGC) and protein kinase G (PKG) are among the highest of any brain region, making a role for NO signaling in striatal plasticity plausible (Ariano, 1983; Ding et al., 2004) . Indeed, NO has been implicated in striatal synaptic plasticity, but its role is controversial Sammut et al., 2007) , with most of the available data suggesting it is a permissive modulator of eCb-dependent LTD (eCb-LTD) (Centonze et al., , 2001 .
RESULTS

NO Signaling Produced LTD of Glutamatergic Synapses
To assess the potential role of NO signaling in striatal synaptic plasticity, excitatory post-synaptic currents (EPSCs) evoked in SPNs by electrical stimulation of corticostriatal axons were monitored before, during, and after the application of the NO donor (S)-nitroso-N-acetyl-D,L-penicillamine (SNAP, 100 mM) to ex vivo parasagittal brain slices of mouse forebrain ( Figure 1A ). In this preparation, cortical axons can be stimulated electrically without directly activating striatal neurons, unlike the coronal brain slice (Kawaguchi et al., 1989) . Transient application of SNAP led to a persistent depression of corticostriatal EPSCs ( Figure 1B ). To verify that our electrical stimulus was not directly exciting SPNs, cortical pyramidal neurons were optogenetically activated to evoke EPSCs; SNAP application also produced a persistent depression of optically evoked corticostriatal EPSCs ( Figure S1A ).
NO can have both direct and indirect effects on proteins involved in synaptic transmission (Garthwaite, 2008) . Because its striatal expression is robust (Ariano, 1983) , our working hypothesis was that the NO donor effects were mediated by soluble GC (sGC) activation. NO stimulates sGC, increasing cytoplasmic cyclic guanosine monophosphate (cGMP) production and the activation of PKG ( Figure 1D ). If NO was acting through this signaling cascade, its effects should be mimicked by analogs of cGMP and blocked by inhibitors of PKG. Indeed, antagonism of PKG by including Rp-8-Br-PET-cGMPS (3 mM) in the patch pipette blocked the effects of SNAP ( Figure 1C ), and brief bath application of the membrane-permeable cGMP analog 8-bromo-cGMP (8Br-cGMP, 500 mM) produced a robust and persistent depression of corticostriatal EPSCs, mimicking SNAP ( Figure 1E ). Moreover, the ability of SNAP to decrease EPSC amplitudes was occluded in cells that had been pre-incubated in 8Br-cGMP ( Figure S1B ). The effects of cGMP analogs on corticostriatal EPSCs were similar in direct pathway SPNs (dSPNs) and indirect pathway SPNs (iSPNs) ( Figure 1F ), consistent with the broad striatal distribution of signaling molecules in the NO pathway (Bredt et al., 1990; Vincent, 1994) .
Because activation of the NO/cGMP/PKG pathway has been shown to augment the activity of cholinergic interneurons (Centonze et al., 2001) , the effect of SNAP was examined in the presence of antagonists of cholinergic signaling. Perfusion of the nicotinic receptor antagonist mecamylamine (10 mM) and the muscarinic receptor antagonist scopolamine (10 mM) prior to and throughout SNAP perfusion did not alter the depression of corticostriatal EPSCs ( Figure 1G ).
To rule out any effects of cellular dialysis with the patch electrode, experiments using SNAP and 8Br-cGMP were also performed in the perforated patch recording configuration. The responses observed were similar to those seen in whole cells ( Figure S1C ). Because the NO-induced reduction in evoked EPSC amplitude persisted for as long as recordings could be maintained, it will be referred to as NO-LTD.
Optogenetic Activation of PLTS Interneurons Induced NO-LTD
Although the effects of SNAP and cGMP analogs were consistent and robust, this does not prove that NO signaling is engaged by the striatal circuitry to control synaptic strength (Feelisch, 1998) . In the striatum, neuronal nitric oxide synthase (nNOS) is expressed robustly only in interneurons that co-express somatostatin, neuropeptide Y, and gamma amino butyric acid (GABA) (Tepper et al., 2010) . Because of their distinctive physiological properties, these cells also are referred to as persistent and low threshold spiking interneurons (PLTSIs). If NO is a bona fide modulator of plasticity, the activation of PLTSIs and their To test this hypothesis, we used optogenetic methods to selectively express channelrhodopsin2 (ChR2) in striatal PLTSIs (Holley et al., 2015; Witten et al., 2011; Zhang et al., 2006) (Figures 2A and  S2A ). In ex vivo brain slices from these mice, SPNs were sorted into two groups: those in which full-field optogenetic stimulation of PLTSIs evoked GABAergic responses (coupled) and those that showed no response (no coupling) ( Figure S2B ). In SPNs coupled to PLTSIs, optical stimulation for 5 min at 15 Hz, a firing frequency that spontaneously active PLTSIs do not normally achieve in slice, led to a robust LTD at corticostriatal synapses (Figures 2B and S2C) . Exciting PLTSIs to firing frequencies lower than 15 Hz, or stimulating for shorter durations, failed to elicit LTD ( Figure S2D ). As expected, when the nNOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 100 mM) or the PKG inhibitor Rp8Br (3 mM) was applied throughout the recording period, LTD induction was blocked ( Figure 2C and 2D) . Similarly, pre-incubation of slices with SNAP occluded PLTS induction of LTD ( Figure S2E ). In contrast, in SPNs where optical stimulation failed to evoke GABAergic responses (possibly because optical stimulation was ineffective in activating PLTSIs), the same stimulation protocol had no effect on corticostriatal synaptic transmission ( Figures 2D and S2B ). Taken together, these data argue that NO signaling originating from PLTSIs induces LTD at corticostriatal synapses.
NO-LTD Was Independent of eCb Signaling and Expressed Post-synaptically
Phenomenologically, the LTD induced by NO signaling (NO-LTD) was very similar to that induced by eCb signaling (eCb-LTD). However, the two forms of LTD had very different determinants. First, NO-LTD induced by cGMP analogs in iSPNs and dSPNs was unaffected by antagonizing D2 dopamine receptors with sulpiride (1 mM) ( Figure S3A ). Second, NO-LTD induced by cGMP analogs in iSPNs and dSPNs was unaffected by antagonizing CB1 eCb receptors with AM251 (2 mM) ( Figure S3A ). Third, NO-LTD was unaffected by dialyzing neurons with the Ca 2+ chelator BAPTA (20 mM) ( Figure S3B ). Each of these interventions is known to block eCb-LTD (Kreitzer and Malenka, 2008; Mathur and Lovinger, 2012) . Another difference between these forms of plasticity was that NO-LTD was readily induced at thalamostriatal glutamatergic synapses, in contrast to eCb-LTD (Wu et al., 2015) ( Figures S3C and S3D) .
One of the most important features of eCb-LTD is that while it is induced post-synaptically in SPNs, it is expressed pre-synaptically as a reduction in glutamate release probability (Kreitzer and Malenka, 2008; Mathur and Lovinger, 2012) . Four observations support the proposition that unlike eCb-LTD, NO-LTD was expressed post-synaptically. First, the expression of NO-LTD was not accompanied by a change in paired-pulse ratio, a hallmark of pre-synaptic LTD ( Figure S3E) . Second, the induction of NO-LTD was independent of pre-synaptic activity; cessation of afferent fiber stimulation during the application of 8Br-cGMP had no effect on the magnitude of NO-LTD (Figure S3F) , unlike eCb-LTD (Adermark et al., 2009 ). Third, intracellular dialysis of D15-a polypeptide previously shown to disrupt the interaction between dynamin and amphiphysin, which is crucial for AMPAR endocytosis (Carroll et al., 1999; Morishita et al., 2005 )-blocked NO-LTD expression, while dialysis of a scrambled peptide had no effect on NO-LTD ( Figures 3A and  3B) . Moreover, D15 dialysis did not alter eCb-LTD induced by the metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine (DHPG; 100 mM) ( Figure 3B ). Fourth, transient application of 8Br-cGMP persistently decreased the amplitude of EPSCs evoked by uncaging of glutamate at visualized SPN spines ( Figures 3C-3F ). Taken together, these results provide strong evidence for a post-synaptic locus of NO-LTD expression, contrasting it with other forms of LTD described in the striatum.
NO Signaling Blocked eCb-LTD Induction
Are NO-LTD and eCb-LTD completely independent? As shown above, NO-LTD does not depend upon signaling events (e.g., CB1R or D2R activation) known to be necessary for induction of eCb-LTD. But could NO signaling blunt eCb-LTD? This would help to explain why the two forms of LTD have not been distinguished to date. The core mechanisms controlling eCb-LTD are well described, making pursuit of this aim tractable ( Figure 4A ) (Mathur and Lovinger, 2012) . As a first step toward characterizing their interaction, NO-LTD was induced by SNAP (100 mM) and a positive allosteric modulator of sGC (BAY-41-2272, 10 mM) (Stasch et al., 2001) ; BAY-41-2272 was used because it potentiated the ability of SNAP to induce LTD, was inhibited by Rp8Br and had no effect on its own (Figures S4A and S4B) (Stasch et al., 2001) . SPNs were then held at À50 mV, afferent fibers stimulated at low frequency, and the mGluR agonist DHPG (100 mM) applied; normally, this is a very robust means of inducing eCb-LTD (Mathur and Lovinger, 2012; Surmeier et al., 2009) (Figure 4B ). However, in this situation, the protocol failed to induce a lasting change in EPSC amplitude (Figure 4B) , arguing that NO-LTD blocked eCb-LTD induction. Bath application of 8Br-cGMP had a very similar effect, disrupting eCb-LTD ( Figure S4C ). The ability of NO signaling to disrupt eCb-LTD was not pre-synaptic in origin as direct application of the CB1R agonist WIN55,212-2 mesylate (WIN) induced a robust LTD in the presence of SNAP and BAY-41-2272 ( Figure 4C) . The other possibility is that NO signaling blunted eCb generation. The production of eCbs by SPNs requires the opening of L-type Ca 2+ channels and an elevation in intracellular Ca 2+ concentration (Mathur and Lovinger, 2012) . In endocrine cells, phosphorylation of L-type channels by PKG decreases their opening (Mahapatra et al., 2012) , raising the possibility that NO signaling was suppressing dendritic L-type channels required for sustained eCb synthesis. Indeed, co-application of SNAP (100 mM) and BAY-41-2272 (10 mM) decreased SPN intraspine Ca 2+ transients evoked by somatic depolarization (Figure 4D and 4E) . Antagonism of L-type channels with isradipine eliminated the effects of SNAP/BAY on intraspine Ca 2+ transients, confirming the L-type specificity of the modulation ( Figure 4D ). Thus, NO signaling disrupted the induction of eCb-LTD at least in part by attenuating activity-dependent, post-synaptic Ca 2+ entry through L-type channels (Figure 4F ).
DISCUSSION
The data presented make the case that NO release by PLTSIs induces a post-synaptically expressed form of LTD at SPN axospinous glutamatergic synapses. Although common in other regions of the brain (Garthwaite and Boulton, 1995; Hö lscher, 1997; Susswein et al., 2004) , this is the first demonstration that striatal SPNs manifest this form of plasticity, complementing post-synaptically expressed LTP (Surmeier et al., 2009) . The molecular mechanisms underlying NO-LTD remain to be fully elucidated, but our results point clearly to AMPA receptor endocytosis. Elsewhere, PKG, which was necessary for NO-LTD, is known to regulate the activity of DARPP-32 and protein phosphatase 1, both of which have been implicated in phosphorylation of the GluA2 AMPAR subunit (Walaas et al., 2011) .
How does the existence of NO-LTD change our understanding of the striatal network? PLTSIs appear to be part of a corticostriatal feed-forward circuit that is activated in parallel with SPNs (Tepper et al., 2010) . Thus, NO-LTD could counterpoise dopamine-dependent potentiation of glutamatergic synaptic strength in SPNs during goal-based learning, helping to maintain a stable level of regional responsiveness by diminishing the strength of inactive synapses neighboring those undergoing potentiation. For this mechanism to work, the signaling mechanisms governing LTP induction would have to oppose those of NO-LTD. As Ca 2+ entry through NMDA receptors is necessary for LTP induction in SPNs (Shen et al., 2008) , phosphodiesterase 1, a striatally enriched, Ca 2+ /calmodulin-dependent phosphodiesterase that preferentially degrades cGMP, might mediate this interaction (Bender and Beavo, 2006 ). An additional possibility may be that NO released from PLTSIs also simultaneously tunes GABAergic inputs within the striatum, specifically from other interneurons onto SPNs, a possibility that has been described elsewhere (Nugent et al., 2007; Sagi et al., 2014) .
In disease states, deficits in NO-LTD could contribute to pathological remodeling of the striatal circuitry. For example, in models of Parkinson's disease (PD), striatal NO signaling falls (Sancesario et al., 2004) . The loss of feed-forward NO-LTD could contribute to hyperactivity of iSPNs and hypokinetic symptoms of the disease (Albin et al., 1989) . The sustained elevation in iSPN activity appears to drive profound homeostatic pruning of corticostriatal synapses (Day et al., 2006; Fieblinger et al., 2014) , disrupting patterns of connectivity shaped by experience. An impairment in NO-LTD might also contribute to levodopa-induced strengthening of dSPN corticostriatal synapses and dyskinesia in PD (Picconi et al., 2011) . How pathological changes in NO signaling preferentially effect dSPNs and iSPNs requires further study.
EXPERIMENTAL PROCEDURES
Tissue Preparation
All experiments were performed in accordance with the Northwestern University Animal Care and Use Committee and NIH guidelines. 6-to 12-week-old male hemizygous C57Bl/6 mice expressing EGFP under control of either the Drd1a or Drd2 receptor regulatory elements; Thy1-ChR2 mice; SST-IRES-Cre mice (Sst tm2.1(cre)Zjh /J), and KH288 mice developed by the GENSAT Project were used. Mice were killed by decapitation and the brain removed in artificial cerebral spinal fluid (ACSF). Para-sagittal brain slices containing striatum were cut at 275-300 mM, and slices were incubated in 30 C-33 C ACSF until recording.
Electrophysiology
After incubation, slices were transferred to a recording chamber perfused with oxygenated ACSF at 30 C-33 C. Cells were filled with a Cs-based internal. SPNs were voltage-clamped at À70 mV and stimuli delivered at 0.1 Hz through a concentric bipolar electrode placed in the cortex in the presence of 10 mM gabazine to block GABA A currents. Optical stimuli were delivered through the epifluorescent light path using an LED light source (CoolLED). Access resistance was monitored throughout recording and cells in which there was a change >20% of baseline were excluded.
Viral Gene Delivery
For optogenetic experiments, a cre-dependent AAV-ChR2 vector was injected into the striatum or thalamus of SST-IRES-Cre or KH288-Cre mice, respectively. Mice were sacrificed 2-3 weeks postinfection.
Two-Photon Laser Scanning Microscopy iSPNs were identified by somatic EGFP expression. Following patch rupture, the internal solution was allowed to equilibrate for 10-15 min before imaging.
Ca 2+ Imaging
SPNs were loaded with 25 mM Alexa 568 and 600 mM Fluo 5F via the recording electrode, which contained a CsMeSO 3 internal. Green fluorescent line-scan signals were acquired from dendritic spines 200 ms before a 300-ms voltage step from À70 to 0 mV. Changes in Fluo 5F fluorescence were measured as DF/Fo.
Two-Photon Laser Uncaging of Glutamate
Glutamate uncaging was achieved using a Verdi/Mira laser system. 5 mM MNI-glutamate was superfused over the slice at 0.4 ml/hr using a syringe pump and multi-barreled perfusion manifold (Cell MicroControls). Glutamate was uncaged adjacent to individual spines using 1-ms pulses of 725-nm light. Photolysis power was tuned via a third Pockels cell modulator (Con Optics) to achieve uncaged-EPSCs (uEPSCs) % 5 pA. uEPSC amplitudes were measured from averaged (five repetitions) traces.
Chemical and Reagents
Rp-8-Br-PET-cGMPS was obtained from Biolog Life Science Institute, L-NAME was obtained from Sigma Aldrich, and all other reagents were obtained from Tocris. Custom peptides were synthesized by the Stanford peptide facility and used at a concentration of 1-2 mM.
Data Analysis and Statistics
The magnitude of LTD was calculated as a percentage of the baseline (minutes 0-5 of recording time). Unless otherwise noted, the average of minutes 30-35 of each recording was used to calculate effects of drug application. Time series data are reported as median, first and third quartiles (whiskers), and outliers removed. Data reported in box plots represent the median, first and third quartiles, and minimum and maximum of data (whiskers) with the outlier removed. dSPNs and iSPNs were combined in datasets unless specified (e.g., Figures 1E and 1F ).
An extended description of the experimental procedures is included in the Supplemental Experimental Procedures.
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